Prophylactic Cranial Irradiation in Small-Cell Lung Cancer

Prophylactic Cranial Irradiation in Small-Cell Lung Cancer Gary Y. Yang, Richard H. Matthews Oncologist 2000; 5: 293-298 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in lung cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Appreciate the survival impact of PCI in small cell lung cancer patients in complete remission. Understand the several factors involved in toxicity to cerebral function, and how best to manage the cancer while minimizing hazards of cerebral dysfunction. Distinguish more successful PCI regimens from less successful regimens for reducing the hazard of brain metastases. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Apr. 16, 2002 Most Recent Review: October 13, 2005* Most Recent Update: Apr. 16, 2002 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.